Lam Research
US.LRCX
307.65
+14.99
+5.12%
Lam Research
307.65
+14.99
+5.12%
Collector offline (last heartbeat: 19209s ago)
· 2026-09-04 20:02
Pre-market
303.66
+3.76%
After-hours
307.48
-0.06%
Overnight
298.90
+2.13%
Revenue annual, last 8 years
Latest year +26.02% YoY
Margins
- Gross margin
- 50.47%
- Operating margin
- 35.29%
- Net margin
- 31.27%
Key ratios & quality
- Enterprise value
- 383.12B
- PEG ratio
- 3.10
- Altman Z-Score
- 25.60
PEG uses trailing P/E against the 3-year net income growth rate (17.22%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 25.60, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.65B | 10.04B | 14.63B | 17.23B | 17.43B | 14.91B | 18.44B | 23.23B |
| Gross profit | 4.36B | 4.61B | 6.81B | 7.87B | 7.78B | 7.05B | 8.98B | 11.73B |
| Selling & admin expenses | 702.41M | 682.48M | 829.88M | 885.74M | 832.75M | 868.25M | 981.70M | 1.15B |
| Research & development | 1.19B | 1.25B | 1.49B | 1.60B | 1.73B | 1.90B | 2.10B | 2.38B |
| Operating profit | 2.46B | 2.67B | 4.48B | 5.38B | 5.22B | 4.28B | 5.90B | 8.20B |
| Pretax profit | 2.45B | 2.57B | 4.37B | 5.19B | 5.11B | 4.36B | 5.96B | 8.26B |
| Tax | 255.14M | 323.23M | 462.35M | 587.83M | 598.28M | 532.45M | 599.91M | 997.08M |
| Net profit | 2.19B | 2.25B | 3.91B | 4.61B | 4.51B | 3.83B | 5.36B | 7.27B |
| Basic EPS | 1 | 2 | 3 | 3 | 3 | 3 | 4 | 6 |
| Diluted EPS | 1.37 | 1.51 | 2.69 | 3.28 | 3.32 | 2.90 | 4.15 | 5.76 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.72B | 5.17B | 5.32B | 5.34B | 5.84B | 6.72B |
| Gross profit | 2.31B | 2.59B | 2.68B | 2.65B | 2.91B | 3.48B |
| Selling & admin expenses | 226.02M | 268.40M | 279.35M | 267.65M | 280.31M | 322.33M |
| Research & development | 525.90M | 580.18M | 576.45M | 573.31M | 583.20M | 642.92M |
| Operating profit | 1.56B | 1.74B | 1.83B | 1.81B | 2.05B | 2.51B |
| Pretax profit | 1.54B | 1.78B | 1.86B | 1.84B | 2.01B | 2.56B |
| Tax | 206.06M | 58.89M | 290.50M | 242.62M | 186.10M | 277.86M |
| Net profit | 1.33B | 1.72B | 1.57B | 1.59B | 1.83B | 2.28B |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | 1.03 | 1.35 | 1.24 | 1.26 | 1.45 | 1.81 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 8.56B | 10.85B | 11.65B | 12.29B | 13.23B | 12.88B | 14.52B | 15.61B |
| Cash & ST investments | 5.43B | 6.71B | 5.73B | 3.66B | 5.34B | 5.85B | 6.39B | 5.58B |
| Inventory | 1.54B | 1.90B | 2.69B | 3.97B | 4.82B | 4.22B | 4.31B | 4.28B |
| Total assets | 12.00B | 14.56B | 15.89B | 17.20B | 18.78B | 18.74B | 21.35B | 23.53B |
| Total current liabilities | 2.37B | 3.16B | 3.53B | 4.56B | 4.18B | 4.34B | 6.57B | 5.94B |
| Short-term debt | 667.13M | 839.88M | 11.35M | 7.38M | 8.36M | 504.81M | 754.31M | 4.07M |
| Long-term debt | 3.82B | 4.96B | 4.95B | 4.96B | 4.96B | 4.47B | 3.72B | 3.72B |
| Total liabilities | 7,278,029,000.00 | 9,375,558,000.00 | 9,864,964,000.00 | 10,917,266,000.00 | 10,571,471,000.00 | 10,205,274,000.00 | 11,483,641,000.00 | 11,058,822,000.00 |
| Total equity | 4.72B | 5.18B | 6.03B | 6.28B | 8.21B | 8.54B | 9.86B | 12.47B |
| Retained earnings | 9.93B | 11.52B | 14.68B | 18.45B | 22.03B | 24.81B | 28.99B | 34.95B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 13.46B | 14.52B | 14.81B | 14.02B | 13.30B | 15.61B |
| Cash & ST investments | 5.45B | 6.39B | 6.69B | 6.18B | 4.75B | 5.58B |
| Inventory | 4.46B | 4.31B | 4.10B | 4.04B | 4.00B | 4.28B |
| Total assets | 19.97B | 21.35B | 21.90B | 21.39B | 20.79B | 23.53B |
| Total current liabilities | 5.49B | 6.57B | 6.71B | 6.21B | 5.24B | 5.94B |
| Short-term debt | 754.31M | 754.31M | 754.36M | 754.01M | 4.10M | 4.07M |
| Long-term debt | 3.73B | 3.72B | 3.73B | 3.73B | 3.73B | 3.72B |
| Total liabilities | 10,457,205,000.00 | 11,483,641,000.00 | 11,707,459,000.00 | 11,245,745,000.00 | 10,207,131,000.00 | 11,058,822,000.00 |
| Total equity | 9.51B | 9.86B | 10.19B | 10.15B | 10.58B | 12.47B |
| Retained earnings | 27.56B | 28.99B | 30.23B | 31.50B | 33.00B | 34.95B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.18B | 2.13B | 3.59B | 3.10B | 5.18B | 4.65B | 6.17B | 5.86B |
| Depreciation & amortization | 309.28M | 268.53M | 307.15M | 333.74M | 342.43M | 359.70M | 386.28M | 441.53M |
| Free cash flow | 2.87B | 1.92B | 3.24B | 2.55B | 4.68B | 4.26B | 5.41B | 4.89B |
| Dividends paid | -678.35M | -656.84M | -726.99M | -815.29M | -907.91M | -1.02B | -1.15B | -1.27B |
| Stock buybacks / issuance | -3.77B | -1.36B | -2.67B | -3.86B | -2.01B | -2.83B | -3.42B | -3.83B |
| Ending cash balance | 3.91B | 5.17B | 4.67B | 3.77B | 5.59B | 5.85B | 6.41B | 5.60B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.31B | 2.55B | 1.78B | 1.48B | 1.14B | 1.46B |
| Depreciation & amortization | 97.34M | 98.44M | 101.64M | 103.93M | 116.32M | 119.64M |
| Free cash flow | 1.02B | 2.38B | 1.59B | 1.22B | 809.82M | 1.27B |
| Dividends paid | -295.72M | -295.21M | -291.98M | -327.51M | -325.83M | -325.32M |
| Stock buybacks / issuance | -433.33M | -1.29B | -975.79M | -1.46B | -1.15B | -242.13M |
| Ending cash balance | 5.46B | 6.41B | 6.71B | 6.20B | 4.77B | 5.60B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE % | 38.77 | 45.46 | 69.73 | 74.85 | 62.27 | 45.71 | 58.24 | 65.07 |
| ROA % | 17.90 | 16.96 | 25.67 | 27.84 | 25.08 | 20.40 | 26.73 | 32.38 |
| ROIC % | 24.25 | 23.08 | 37.04 | 42.65 | 37.16 | 28.19 | 38.11 | 47.34 |
| 5-year avg ROE % | 25.64 | 32.25 | 43.00 | 52.78 | 58.22 | 59.60 | 62.16 | 61.23 |
| EBIT margin % | 26.56 | 27.40 | 31.31 | 31.22 | 30.39 | 30.50 | 33.29 | 36.24 |
| FCF / sales % | 29.76 | 19.15 | 22.15 | 14.82 | 26.84 | 28.55 | 29.37 | 21.05 |
| Current ratio | 3.61 | 3.43 | 3.30 | 2.69 | 3.16 | 2.97 | 2.21 | 2.63 |
| Quick ratio | 2.90 | 2.78 | 2.48 | 1.75 | 1.95 | 1.93 | 1.49 | 1.84 |
| Debt / assets | 95.06 | 112.10 | 82.88 | 79.73 | 61.04 | 58.36 | 45.47 | 29.95 |
| LT debt / equity | 80.93 | 95.90 | 82.69 | 79.61 | 60.94 | 52.45 | 37.83 | 29.91 |
| Interest coverage | 21.86 | 15.51 | 21.95 | 29.11 | 28.40 | 24.54 | 34.43 | 53.67 |
| Revenue CAGR (3Y) % | 17.93 | 7.82 | 9.71 | 21.29 | 20.16 | 0.63 | 2.29 | 10.06 |
| Net income CAGR (3Y) % | 33.84 | 9.87 | 17.97 | 28.09 | 26.06 | -0.69 | 5.18 | 17.22 |
| FCF CAGR (3Y) % | 34.71 | 0.91 | 10.78 | -3.85 | 34.48 | 9.53 | 28.47 | 1.50 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE % | 53.14 | 58.24 | 62.26 | 65.56 | 66.76 | 65.07 |
| ROA % | 24.36 | 26.73 | 28.05 | 30.14 | 32.92 | 32.38 |
| ROIC % | 34.11 | 38.11 | 40.98 | 43.41 | 47.07 | 47.34 |
| 5-year avg ROE % | -- | -- | -- | -- | -- | -- |
| EBIT margin % | 32.19 | 33.29 | 34.19 | 34.93 | 35.29 | 36.24 |
| FCF / sales % | 22.14 | 29.37 | 28.33 | 30.23 | 27.70 | 21.05 |
| Current ratio | 2.45 | 2.21 | 2.21 | 2.26 | 2.54 | 2.63 |
| Quick ratio | 1.58 | 1.49 | 1.54 | 1.56 | 1.69 | 1.84 |
| Debt / assets | 47.15 | 45.47 | 43.99 | 44.19 | 35.28 | 29.95 |
| LT debt / equity | 39.22 | 37.83 | 36.59 | 36.76 | 35.24 | 29.91 |
| Interest coverage | 30.33 | 34.43 | 38.12 | 41.93 | 46.25 | 53.67 |
| Revenue CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Manufacturing and servicing of wafer processing semiconductor manufacturing equipment100.00%
Region
China33.83%
Taiwan22.48%
Korea19.39%
Japan9.34%
United States6.58%
Southeast Asia5.36%
Europe3.01%
Quote time 2026-09-04 20:02:24
For reference only, not investment advice.